These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 14711103)
1. Effect of fetal macrosomia on human placental glucose transport and utilization in insulin-treated gestational diabetes. King RG; Osmond DT; Brennecke SP; Gude NM J Perinat Med; 2003; 31(6):475-83. PubMed ID: 14711103 [TBL] [Abstract][Full Text] [Related]
2. Placental glucose transport and utilisation is altered at term in insulin-treated, gestational-diabetic patients. Osmond DT; King RG; Brennecke SP; Gude NM Diabetologia; 2001 Sep; 44(9):1133-9. PubMed ID: 11596668 [TBL] [Abstract][Full Text] [Related]
3. Decreased maternal serum adiponectin and increased insulin-like growth factor-1 levels along with increased placental glucose transporter-1 expression in gestational diabetes mellitus: Possible role in fetal overgrowth. Balachandiran M; Bobby Z; Dorairajan G; Gladwin V; Vinayagam V; Packirisamy RM Placenta; 2021 Jan; 104():71-80. PubMed ID: 33285436 [TBL] [Abstract][Full Text] [Related]
4. GDM-Induced Macrosomia Is Reversed by Cav-1 via AMPK-Mediated Fatty Acid Transport and GLUT1-Mediated Glucose Transport in Placenta. Yao G; Zhang Y; Wang D; Yang R; Sang H; Han L; Zhu Y; Lu Y; Tan Y; Shang Z PLoS One; 2017; 12(1):e0170490. PubMed ID: 28125642 [TBL] [Abstract][Full Text] [Related]
5. Association of hyperglycaemia with the placenta of GDM-induced macrosomia with normal pre-pregnancy BMI and the proliferation of trophoblast cells. Zheng Y; Huang M; Lu X; Xu J; Han Y; Ji J; Han Y J Obstet Gynaecol; 2022 Aug; 42(6):1759-1768. PubMed ID: 35260025 [TBL] [Abstract][Full Text] [Related]
6. ARHGEF11 affecting the placental insulin signaling pathway in fetal macrosomia of normal glucose tolerance pregnant women. Zhang W; Su R; Lin L; Yang H Placenta; 2018 Mar; 63():7-14. PubMed ID: 29486856 [TBL] [Abstract][Full Text] [Related]
7. Placental fatty acid transfer: a key factor in fetal growth. Larqué E; Pagán A; Prieto MT; Blanco JE; Gil-Sánchez A; Zornoza-Moreno M; Ruiz-Palacios M; Gázquez A; Demmelmair H; Parrilla JJ; Koletzko B Ann Nutr Metab; 2014; 64(3-4):247-53. PubMed ID: 25300267 [TBL] [Abstract][Full Text] [Related]
8. Alteration in Expression and Methylation of IGF2/H19 in Placenta and Umbilical Cord Blood Are Associated with Macrosomia Exposed to Intrauterine Hyperglycemia. Su R; Wang C; Feng H; Lin L; Liu X; Wei Y; Yang H PLoS One; 2016; 11(2):e0148399. PubMed ID: 26840070 [TBL] [Abstract][Full Text] [Related]
9. Detection of pregnancies with high risk of fetal macrosomia among women with gestational diabetes mellitus. Suhonen L; Hiilesmaa V; Kaaja R; Teramo K Acta Obstet Gynecol Scand; 2008; 87(9):940-5. PubMed ID: 18728914 [TBL] [Abstract][Full Text] [Related]
10. Placental MFSD2a transporter is related to decreased DHA in cord blood of women with treated gestational diabetes. Prieto-Sánchez MT; Ruiz-Palacios M; Blanco-Carnero JE; Pagan A; Hellmuth C; Uhl O; Peissner W; Ruiz-Alcaraz AJ; Parrilla JJ; Koletzko B; Larqué E Clin Nutr; 2017 Apr; 36(2):513-521. PubMed ID: 26869380 [TBL] [Abstract][Full Text] [Related]
11. Components of metabolic syndrome and their impact on fetal growth in women with gestational diabetes mellitus. Zawiejska A; Wender-Ozegowska E; Brazert J; Sodowski K J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():5-18. PubMed ID: 18955750 [TBL] [Abstract][Full Text] [Related]
12. Placental transport and metabolism in fetal overgrowth -- a workshop report. Jansson T; Cetin I; Powell TL; Desoye G; Radaelli T; Ericsson A; Sibley CP Placenta; 2006 Apr; 27 Suppl A():S109-13. PubMed ID: 16542722 [TBL] [Abstract][Full Text] [Related]
13. Factors predicting the need for insulin therapy in patients with gestational diabetes mellitus. Sapienza AD; Francisco RP; Trindade TC; Zugaib M Diabetes Res Clin Pract; 2010 Apr; 88(1):81-6. PubMed ID: 20071050 [TBL] [Abstract][Full Text] [Related]
14. A clinical study which relates to a theoretical simulation of the glucose transport in the human placenta under various diabetic conditions. Barta E; Drugan A J Perinat Med; 2016 May; 44(4):405-10. PubMed ID: 26584352 [TBL] [Abstract][Full Text] [Related]
15. No evidence of attenuation of placental insulin-stimulated Akt phosphorylation and amino acid transport in maternal obesity and gestational diabetes mellitus. Castillo-Castrejon M; Jansson T; Powell TL Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1037-E1049. PubMed ID: 31573844 [TBL] [Abstract][Full Text] [Related]
16. Myostatin in the placentae of pregnancies complicated with gestational diabetes mellitus. Peiris HN; Lappas M; Georgiou HM; Vaswani K; Salomon C; Rice GE; Mitchell MD Placenta; 2015 Jan; 36(1):1-6. PubMed ID: 25443639 [TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factors I and II peptide and messenger RNA levels in macrosomic infants of diabetic pregnancies. Roth S; Abernathy MP; Lee WH; Pratt L; Denne S; Golichowski A; Pescovitz OH J Soc Gynecol Investig; 1996; 3(2):78-84. PubMed ID: 8796812 [TBL] [Abstract][Full Text] [Related]
18. Neonatal macrosomia and hypoglycaemia in children of mothers with insulin-treated gestational diabetes mellitus. Stenninger E; Schollin J; Aman J Acta Paediatr Scand; 1991 Nov; 80(11):1014-8. PubMed ID: 1750333 [TBL] [Abstract][Full Text] [Related]
19. Gestational diabetes mellitus and macrosomia: a literature review. Kc K; Shakya S; Zhang H Ann Nutr Metab; 2015; 66 Suppl 2():14-20. PubMed ID: 26045324 [TBL] [Abstract][Full Text] [Related]
20. Expression of nutrient transporters in placentas affected by gestational diabetes: role of leptin. Guadix P; Corrales I; Vilariño-García T; Rodríguez-Chacón C; Sánchez-Jiménez F; Jiménez-Cortegana C; Dueñas JL; Sánchez-Margalet V; Pérez-Pérez A Front Endocrinol (Lausanne); 2023; 14():1172831. PubMed ID: 37497352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]